Boosting endogenous dopamine production: a novel therapeutic approach for Parkinson's disease.

Douma, Erik H; Smidt, Marten P; van der Heide, Lars P

Douma, Erik H; Smidt, Marten P; van der Heide, Lars P.

Afiliación

Douma EH; Parkinnova Therapeutics, Science Park 904, 1098 XH, Amsterdam, The Netherlands.
Smidt MP; Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, The Netherlands.
van der Heide LP; Swammerdam Institute for Life Sciences, University of Amsterdam, Science Park 904, 1098 XH, Amsterdam, The Netherlands. Electronic address: l.p.vanderheide@uva.nl.

Trends Mol Med ; 2024 Jun 25.

Article en En | MEDLINE | ID: mdl-38926032

ABSTRACT

ABSTRACT

Innovative therapeutic strategies are urgently needed for Parkinson's disease due to limited efficacy of current treatments and a weak therapeutic pipeline. In this forum article, we propose targeting tyrosine hydroxylase phosphorylation as a novel mechanism of action to address this critical need.

Palabras clave

Parkinson's disease; Ser40 phosphorylation; dopamine; levodopa; phosphodiesterase; tyrosine hydroxylase

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Trends Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google